Sunshine Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sunshine Biopharma generated cash of -$8,775,111, which is less than the previous year. Cash used in financing activities reached the amount of $3,425,587 last year. Net change in cash is therefore -$5,534,090.
Cash Flow
| 2014 | -538.59K | 0 | 650.77K |
|---|---|---|---|
| 2015 | -867.64K | -623.60K | 1.39M |
| 2016 | -314.18K | -3.43K | 324.62K |
| 2017 | -543.52K | -84.00K | 670.70K |
| 2018 | -512.80K | -13.90K | 527.64K |
| 2019 | -495.79K | -15.27K | 442.25K |
| 2020 | -657.29K | -1.19K | 1.60M |
| 2021 | -1.82M | 0 | 2.90M |
| 2022 | -5.24M | -14.61M | 39.46M |
| 2023 | -8.77M | -656.15K | 3.42M |
SBFMW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 21.82M | 2.04M | 989.88K | 40.50K | 115.21K | 107.53K | 57.45K | 50.79K | 143.42K | 31.24K |
Operating activities | ||||||||||
Net income | -4.50M | -26.74M | -12.43M | -2.78M | -1.66M | -2.15M | -1.04M | -3.49M | -1.65M | -1.93M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 149.14K | 25.16K | 12.74K | 14.06K | 13.77K | 49.36K | 6.62K | 60.73K | 4.25K | 0 |
Stock-based compensation expense | 0 | 0 | 918K | 50K | 261.68K | 0 | 427.4K | 0 | 116.5K | 1.25M |
| Deferred income tax benefit | 0 | 0 | 918K | 50K | 261.68K | 0 | 427.4K | 0 | 116.5K | 1.25M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -594.14K | -524.48K | -5.88K | -1.48K | -430 | -15.44K | 0 | 0 | 0 | 0 |
Inventories | -2.36M | 42.98K | -81.87K | -7.86K | -15.91K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.36M | 3.35M | -18.15K | -35.01K | -18.69K | 61.62K | -8.80K | -18.96K | 92.31K | 10.95K |
Cash generated by operating activities | -8.77M | -5.24M | -1.82M | -657.29K | -495.79K | -512.80K | -543.52K | -314.18K | -867.64K | -538.59K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -82.25K | -304.99K | 0 | -1.19K | -860 | -18.85K | -3.71K | -3.43K | -623.60K | 0 |
Acquisitions Net | 0 | -14.34M | 0 | 0 | 0 | 4.94K | -80.29K | 0 | 0 | 0 |
Cash generated by investing activities | -656.15K | -14.61M | 0 | -1.19K | -15.27K | -13.90K | -84.00K | -3.43K | -623.60K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 4.08M | 30.36M | 0 | 0 | 0 | 0 | 63.91K | 104.12K | 236.55K | 153.33K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -541.14K | -99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -125.99K | -1.93M | -475.32K | -106.6K | 416.46K | -194.18K | 570.56K | 0 | 1.16M | 0 |
Cash used in financing activities | 3.42M | 39.46M | 2.90M | 1.60M | 442.25K | 527.64K | 670.70K | 324.62K | 1.39M | 650.77K |
Net Change In Cash | -5.53M | 19.78M | 1.05M | 949.38K | -74.71K | 7.68K | 50.07K | 6.65K | -92.62K | 112.18K |
Cash at end of period | 16.29M | 21.82M | 2.04M | 989.88K | 40.50K | 115.21K | 107.53K | 57.45K | 50.79K | 143.42K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |